LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Nintedanib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4282 | 4513 | 0.9488 | 0.9294 |
MDA-MB-231 | NU7441 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4212 | 4513 | 0.9333 | 0.9082 |
MDA-MB-231 | Dactolisib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1357 | 4513 | 0.3006 | 0.0369 |
MDA-MB-231 | NVP-TAE684 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1814 | 4513 | 0.4019 | 0.1764 |
MDA-MB-231 | Palbociclib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2231 | 4513 | 0.4944 | 0.3037 |
MDA-MB-231 | PD0325901 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1295 | 4513 | 0.2869 | 0.0180 |
MDA-MB-231 | PD0325901 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1069 | 4513 | 0.2369 | -0.0508 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4916 | 4513 | 1.0893 | 1.1230 |
MDA-MB-231 | PD184352 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3376 | 4513 | 0.7480 | 0.6530 |
MDA-MB-231 | Pelitinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3138 | 4513 | 0.6952 | 0.5803 |
MDA-MB-231 | PF431396 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1535 | 4513 | 0.3402 | 0.0913 |
MDA-MB-231 | PF477736 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2190 | 4513 | 0.4853 | 0.2913 |
MDA-MB-231 | PF562271 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2354 | 4513 | 0.5216 | 0.3412 |
MDA-MB-231 | PHA-665752 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4645 | 4513 | 1.0291 | 1.0401 |
MDA-MB-231 | PHA-793887 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 924 | 4513 | 0.2048 | -0.0951 |
MDA-MB-231 | PI103 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1835 | 4513 | 0.4066 | 0.1829 |
MDA-MB-231 | PLX-4720 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4404 | 4513 | 0.9757 | 0.9666 |
MDA-MB-231 | QL-X-138 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2766 | 4513 | 0.6128 | 0.4668 |
MDA-MB-231 | QL-XII-47 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1211 | 4513 | 0.2683 | -0.0076 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1004 | 4513 | 0.2224 | -0.0708 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1180 | 4513 | 0.2614 | -0.0171 |
MDA-MB-231 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4116 | 4513 | 0.9121 | 0.8789 |
MDA-MB-231 | Ruxolitinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4119 | 4513 | 0.9127 | 0.8798 |
MDA-MB-231 | XL147 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 5016 | 4513 | 1.1114 | 1.1535 |
MDA-MB-231 | Saracatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2835 | 4513 | 0.6281 | 0.4879 |